Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis

Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis

Anemia is a common feature of both benign and malignant hematologic diseases. Beta-thalassemia (β-thalassemia) syndromes are a group of hereditary disorders characterized by ineffective erythropoiesis, due to a genetic deficiency in the synthesis of the beta chains of hemoglobin, often accompanied b...

Full description

Bibliographic Details
Main Authors: Eleftheria Hatzimichael, Despoina Timotheatou, Epameinondas Koumpis, Leonidas Benetatos, Alexandros Makis
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Diseases
Subjects:
luspatercept
anemia
beta-thalassemia
myelofibrosis
myelodysplastic syndromes
ineffective erythropoiesis
Online Access:https://www.mdpi.com/2079-9721/10/4/85

Internet

https://www.mdpi.com/2079-9721/10/4/85

Similar Items